Train harder · Free ship $75+ · Gear up now
tirzepatide metabolic syndrome

tirzepatide metabolic syndrome Frontiers Frontiers | GLP-1/GIP dual agonist

SKU: 24176373646

4.6
USD23.69 USD60.69

Pay in 4 interest-free payments of $5.92 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Oct 9 - Oct 14

Description

Side effects can be mitigated by using lower doses and combining TZD therapy with other medications (SGLT2i and GLP-1 RA) that promote weight loss and sodium excretion [199, 206]

tirzepatide metabolic syndrome Frontiers Frontiers | GLP-1/GIP dual agonist

Mechanism of Action The mechanism of action of Tirzepatide is defined by its function as a biased agonist at two distinct G-protein coupled receptors (GPCRs): the glucagon-like peptide-1 receptor (GLP-1R) and the glucose-dependent insulinotropic polypeptide receptor (GIPR)

tirzepatide metabolic syndrome Frontiers Frontiers | GLP-1/GIP dual agonist

Tirzepatide demonstrated approximately 5-fold lower affinity at the GLP-1 receptor compared to native GLP-1, and 20-fold lower potency in cellular signaling compared to semaglutide

tirzepatide metabolic syndrome Frontiers Frontiers | GLP-1/GIP dual agonist

10.1371/journal.pone.0050300 12

tirzepatide metabolic syndrome Frontiers Frontiers | GLP-1/GIP dual agonist

The estimated phentermine oral clearance (CL/F) is 8.79 L/h via population pharmacokinetic analysis

tirzepatide metabolic syndrome Frontiers Frontiers | GLP-1/GIP dual agonist
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products